Advertisement
Research Article| Volume 54, ISSUE 2, P181-187, May 1982

Neuraminidase activities in sialidosis and mucolipidosis

  • Masaru Kuriyama
    Correspondence
    Correspondence should be sent to Masaru Kuriyama, Third Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 1208-1 Usuki-cho, Kagoshima, Japan.
    Footnotes
    Affiliations
    Department of Biochemistry and Metabolism, The Tokyo Metropolitan Institute of Medical Science, Honkomagome 3–18, Bunkyo-ku, Tokyo Japan
    Search for articles by this author
  • Tadashi Miyatake
    Affiliations
    Department of Biochemistry and Metabolism, The Tokyo Metropolitan Institute of Medical Science, Honkomagome 3–18, Bunkyo-ku, Tokyo Japan

    Department of Neurology, Jichi Medical School, Tochigi Japan
    Search for articles by this author
  • Misao Owada
    Affiliations
    Department of Pediatrics, Nihon University School of Medicine, Tokyo Japan
    Search for articles by this author
  • Teruo Kitagawa
    Affiliations
    Department of Pediatrics, Nihon University School of Medicine, Tokyo Japan
    Search for articles by this author
  • Author Footnotes
    ∗ Present address: Third Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 1208-1 Usuki-cho, Kagoshima 890, Japan.
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Defects of neuraminidase activities towards sialyloigosaccharides in fibroblasts and leucocytes and enhanced excretion of sialyloligosaccharides in urine were shown in patients with adult type sialidosis with partial deficiency of β-galactosidase and cherry red spot-myoclonus syndrome. No differences in their neuraminidase residual levels and urinary excretion patterns on thin-layer chromatography were found between these two disorders. In mucolipidosis II and III patients, the neuraminidase activities towards sialyloligosaccharides were almost normal in leucocytes, although decreased in fibroblasts. The discrepancy of neuraminidase activities towards 2 →3 and 2 →6 sialyloligosaccharide isomers was not noticed in all cases.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bhavanandan V.P.
        • Yeh A.K.
        • Carabelli R.
        Neuraminidase assay utilizing sialyloligosaccharide substrates with tritium-labeled aglycone.
        Anal. Biochem. 1975; 69: 385-394
        • Cantz M.
        • Messer H.
        Oligosaccharide and ganglioside neuraminidase activities of mucolipidosis I (sialidosis) and mucolipidosis II (I cell disease) fibroblasts.
        Europ. J. Biochem. 1979; 97: 113-118
        • Cantz M.
        • Gehler J.
        • Spranger J.
        Mucolipidosis I — Increased sialic acid content and deficiency of an α-N-acetylneuraminidase in cultured fibroblasts.
        Biochem. Biophys. Res. Commun. 1977; 74: 732-738
        • Den Tandt W.R.
        • Leroy J.G.
        Deficiency of neuraminidase in the sialidoses and the mucolipidoses.
        Hum. Genet. 1980; 53: 383-388
        • Federico A.
        • Cecio A.
        • Battini G.A.
        • Michalski J.C.
        • Strecker G.
        • Guazzi G.C.
        Macular cherry red spot and myoclonus syndrome — Juvenile form of sialidosis.
        J. Neurol. Sci. 1980; 48: 157-169
        • Franceschetti S.
        • Uziel G.
        • Di Donato S.
        • Caimi L.
        • Avanzini G.
        Cherry-red spot myoclonus syndrome and α-neuraminidase deficiency — Neurophysiological, pharmacological and biochemical study in an adult.
        J. Neurol. Neurosurg. Psychiat. 1980; 43: 934-940
        • Hong V.N.
        • Beauregard G.
        • Potier M.
        • Bélisle M.
        • Mameli L.
        • Gatti R.
        • Durand P.
        Studies on the sialidosis — Properties of human leucocyte neuraminidases.
        Biochim. biophys. Acta. 1980; 616: 259-270
        • Kobayashi T.
        • Ohta M.
        • Goto I.
        • Tanaka Y.
        • Kuroiwa Y.
        Adult type mucolipidosis and neuraminidase deficiency — Histological and biochemical studies.
        J. Neurol. 1979; 221: 137-149
        • Kobayashi T.
        • Goto I.
        • Tanaka Y.
        • Yamashita M.
        • Kuroiwa Y.
        Biochemical comparison of the dysmorphic type with the normosomatic type of sialidosis.
        Clin. chim. Acta. 1980; 103: 343-347
        • Kuriyama M.
        • Okada S.
        • Tanaka Y.
        • Umezaki H.
        Adult mucolipidosis with β-galactosidase and neuraminidase deficiencies.
        J. neurol. Sci. 1980; 46: 245-254
        • Kuriyama M.
        • Ariga T.
        • Ando S.
        • Suzuki M.
        • Yamada T.
        • Miyatake T.
        Urinary sialyloligosaccharides in adult type sialidosis — Occurrence of two positional isomers.
        Japan J. exp. Med. 1981; 51: 129-132
        • Kuriyama M.
        • Ariga T.
        • Ando S.
        • Suzuki M.
        • Yamada T.
        • Miyatake T.
        Four positional isomers of sialyloligosaccharides isolated from the urine of the patient with sialidosis.
        J. biol. Chem. 1981; (In press)
        • Kuriyama M.
        • Someya F.
        • Miyatake T.
        • Koseki M.
        Partial characterization and studies of fibroblast and leucocyte neuraminidase activities towards sialyloligosaccharides in adult sialidosis and mucolipidosis II and III.
        Biochim. biophys. Acta. 1981; (In press)
        • Kuriyama M.
        • Someya F.
        • Yamada T.
        • Miyatake T.
        Radioassay method of neuraminidase towards N-acetylneuraminosyl hexasaccharides.
        Clin. chim. Acta. 1982; 119: 73-80
        • Kelly T.E.
        • Graetz G.
        Isolated acid neuraminidase deficiency — A distinct lysosomal storage disease.
        Amer. J. med. Genet. 1977; 1: 31-46
        • Lowden J.A.
        • O'Brien J.S.
        A review of human neuraminidase deficiency.
        Amer. J. hum. Genet. 1979; 31: 1-18
        • Miyatake T.
        • Yamada T.
        • Suzuki M.
        • Pallman B.
        • Sandhoff K.
        • Ariga T.
        • Atsumi T.
        Sialidase deficiency in adult type neuronal storage disease.
        FEBS Lett. 1979; 97: 257-259
        • Miyatake T.
        • Atsumi T.
        • Obayashi T.
        • Mizuno Y.
        • Ando S.
        • Ariga T.
        • Matsui-Nakamura K.
        • Yamada T.
        Adult type neuronal storage disease with neuraminidase deficiency.
        Ann. Neurol. 1979; 6: 232-244
        • Müller O.T.
        • Wenger D.A.
        Mucolipidosis I — Studies of sialidase activity and a prenatal diagnosis.
        Clin. chim. Acta. 1981; 109: 313-324
        • O'Brien J.S.
        Neuraminidase deficiency in the cherry red spot-myoclonus syndrome.
        Biochem. Biophys. Res. Commun. 1977; 79: 1136-1141
        • Okada S.
        • Yutaka T.
        • Kato T.
        • Ikehara C.
        • Yabuuchi H.
        • Okawa M.
        • Inui M.
        • Chiyo H.
        A case of neuraminidase deficiency associated with a partial β-galactosidase defect — Clinical, biochemical and radiological studies.
        Europ. J. Pediat. 1979; 130: 239-249
        • Potier M.
        • Beauregard G.
        • Bélisle M.
        • Mameli L.
        • Hong V.N.
        • Melançon S.B.
        • Dallaire L.
        Neuraminidase activity in the mucolipidoses (Type I, II and III) and the cherry-red spot myoclonus syndrome.
        Clin. chim. Acta. 1979; 99: 97-105
        • Strecker G.
        • Michalski J.P.
        Biochemical basis of six different types of sialidosis.
        FEBS Lett. 1978; 85: 20-24
        • Strecker G.
        • Peers M.C.
        • Michalski J.C.
        • Hondi-Assah T.
        • Fournet B.
        • Spik G.
        • Montreuil J.
        • Farriaux J.P.
        • Moroteaux P.
        • Durand P.
        Structure of nine sialyloligosaccharides accumulated in urine of eleven patients with three different types of sialidosis — Mucolipidosis II and two new types of mucolipidosis.
        Europ. J. Biochem. 1977; 75: 391-403
        • Swallow D.M.
        • Evans L.
        • Stewart G.
        • Thomas P.K.
        • Abrams J.D.
        Sialidosis type 1 — Cherry red spot-myoclonus syndrome with sialidase deficiency and altered electrophoretic mobility of some enzymes known to be glycoproteins, Part 2 (Enzyme studies).
        Ann. Hum. Genet. (Lond.). 1979; 43: 27-35
        • Thomas G.H.
        • Tipton R.E.
        • Chin L.T.
        • Reynolds L.W.
        • Miller C.S.
        Sialidase (α-N-acetylneuraminidase) deficiency — The enzyme defect in an adult with macular cherry-red spots and myoclonus without dementia.
        Clin. Genet. 1978; 13: 369-379
        • Wenger D.A.
        • Tarby T.J.
        • Wharton C.
        Macular cherry-red spots and myoclonus with dementia — Coexistent neuraminidase and β-galactosidase deficiencies.
        Biochem. Biophys. Res. Commun. 1978; 82: 589-595
        • Wiesman U.N.
        • Herschkowitz N.
        Sialidoses (mucolipidoses), clinical pictures.
        in: Svennerholm L. Structure and Function of Gangliosides. Plenum Press, New York, NY1980: 385-399